Intellia Therapeutics, Inc.

NTLANASDAQHealthcare● Active

$13.54

$0.00(-0.03%)

Market Cap$1.5B

P/E Ratio—

52W High$28.25

52W Low$7.31

Avg Volume5.4M

Open$13.83

Beta1.81

Overview

Intellia Therapeutics, Inc. (NTLA) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · NTLA · as of Feb 26, 2026

Latest filing snapshot

377

-26-6.45%vs prior year

Intellia Therapeutics, Inc. (NTLA) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

377

Change (1Y)

-26

Growth % (1Y)

-6.45%

Revenue / Employee

$179.5K

Net Income / Employee

$-1.09M

Market Cap

$1.5B

NTLA Employee Count

2016 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-26	2025-12-31	377	-26	-6.45%
2025-02-27	2024-12-31	403	-123	-23.38%
2024-02-22	2023-12-31	526	-72	-12.04%
2023-02-23	2022-12-31	598	+113	+23.30%
2022-02-24	2021-12-31	485	+173	+55.45%
2021-02-26	2020-12-31	312	+42	+15.56%
2020-02-27	2019-12-31	270	+59	+27.96%
2019-02-27	2018-12-31	211	+16	+8.21%
2018-03-14	2017-12-31	195	+91	+87.50%
2017-03-14	2016-12-31	104	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

BCRX

BioCryst Pharmaceuticals, Inc.

580$1.7B #2

NTLA

Intellia Therapeutics, Inc.YOU

Stoke Therapeutics, Inc.

Spyre Therapeutics, Inc.

73$4.3B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · NTLA peer comparison

About NTLA employees

NTLA Employees · Headcount

Intellia Therapeutics, Inc. (NTLA) employee data is sourced from the annual SEC 10-K filing. As of 2025, Intellia Therapeutics, Inc. had 377 full-time employees globally. Full-time employees only. Global consolidated headcount.

Intellia Therapeutics, Inc. employs 377 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $179,499, reflecting the company's operational efficiency.

Intellia Therapeutics, Inc.'s workforce decreased by 26 (6.45%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Intellia Therapeutics, Inc.'s revenue per employee of $179,499 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

NTLA Employees · 5 questions

As of the latest SEC 10-K filing (2025), Intellia Therapeutics, Inc. had 377 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Intellia Therapeutics, Inc. employee counthow many employees does Intellia Therapeutics, Inc. haveNTLA total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-26